Listed by the USPTO as ARIETI, RUTH SOPHIA
Tech Center 1600 • Art Units: 1600 1635 1636 1674
This examiner grants 46% of resolved cases
ARIETI, RUTH SOPHIA examines in tech center 1600 and art unit 1600. The record includes 91 resolved cases, with an allowance rate of 46.2% and a median of 1245 days to allowance. Interview lift is 71.4%, indicating a strong positive association between interviews and allowance outcomes in the recorded cases.
The leading companies are University of Massachusetts, Intellia Therapeutics Inc., and The Johns Hopkins University. The leading firms are BANNER & WITCOFF, LTD., EDELL, SHAPIRO & FINNAN, LLC, and FISH & RICHARDSON P.C. (TC). The 91-case record makes the measures directional. The low allowance rate supports careful claim development, while the high interview lift makes focused examiner engagement particularly relevant. The 1245-day median favors early prosecution planning.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16999759 | O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 18027671 | METHOD TO IMPROVE PROTEIN QUALITY CONTROL | Non-Final OA | The Johns Hopkins University |
| 17101545 | HIGH THROUGHPUT GENE EDITING SYSTEM AND METHOD | Non-Final OA | Recursion Pharmaceuticals, Inc. |
| 18283699 | TARGETING MULTIPLE T CELL TYPES USING SPHERICAL NUCLEIC ACID VACCINE ARCHITECTURE | Non-Final OA | NORTHWESTERN UNIVERSITY |
| 18036704 | THERAPEUTICS TARGETING TRANSFORMING GROWTH FACTOR BETA FAMILY SIGNALING | Final Rejection | University of Connecticut |
| 18392696 | SECRETED UBE3A FOR TREATMENT OF NEUROLOGICAL DISORDERS | Non-Final OA | University of South Florida |
| 18248974 | RNA COMPOSITIONS AND METHODS FOR INHIBITING LIPOPROTEIN(A) | Final Rejection | SANOFI |
| 18033049 | DUAL AAV VECTOR-MEDIATED DELETION OF LARGE MUTATIONAL HOTSPOT FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | Non-Final OA | Duke University |
| 17442790 | FOCUSED ULTRASOUND FOR NON-INVASIVE FOCAL GENE DELIVERY TO THE MAMMALIAN BRAIN | Final Rejection | The Rockefeller University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy46.2% of resolved applications examined by Ruth Sophia Arieti were allowed (91 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +71.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Ruth Sophia Arieti took 1,245 days on average from filing to allowance.
Ruth Sophia Arieti examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
